ImmuCell Net Income 2010-2024 | ICCC
ImmuCell net income from 2010 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
| ImmuCell Annual Net Income (Millions of US $) |
|
|---|---|
| 2023 | $-6 |
| 2022 | $-2 |
| 2021 | $-0 |
| 2020 | $-1 |
| 2019 | $-1 |
| 2018 | $-2 |
| 2017 | $-0 |
| 2016 | $1 |
| 2015 | $1 |
| 2014 | $-0 |
| 2013 | $0 |
| 2012 | $0 |
| 2011 | $-0 |
| 2010 | $-0 |
| 2009 | $-0 |
| ImmuCell Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2024-06-30 | $-2 |
| 2024-03-31 | $-0 |
| 2023-12-31 | $-1 |
| 2023-09-30 | $-1 |
| 2023-06-30 | $-1 |
| 2023-03-31 | $-2 |
| 2022-12-31 | $-2 |
| 2022-09-30 | $-1 |
| 2022-06-30 | $-1 |
| 2022-03-31 | $1 |
| 2021-12-31 | $0 |
| 2021-09-30 | $0 |
| 2021-06-30 | $0 |
| 2021-03-31 | $-0 |
| 2020-12-31 | $0 |
| 2020-09-30 | $-0 |
| 2020-06-30 | $-1 |
| 2020-03-31 | $-0 |
| 2019-12-31 | $-0 |
| 2019-09-30 | $-1 |
| 2019-06-30 | $-1 |
| 2019-03-31 | $0 |
| 2018-12-31 | $-1 |
| 2018-09-30 | $-0 |
| 2018-06-30 | $-1 |
| 2018-03-31 | $-0 |
| 2017-12-31 | $-0 |
| 2017-09-30 | $-0 |
| 2017-06-30 | $-0 |
| 2017-03-31 | $1 |
| 2016-12-31 | $0 |
| 2016-09-30 | $0 |
| 2016-06-30 | $-0 |
| 2016-03-31 | $0 |
| 2015-12-31 | $0 |
| 2015-09-30 | $0 |
| 2015-06-30 | $0 |
| 2015-03-31 | $0 |
| 2014-12-31 | $0 |
| 2014-09-30 | $0 |
| 2014-06-30 | $-0 |
| 2014-03-31 | $-0 |
| 2013-12-31 | $-0 |
| 2013-09-30 | $0 |
| 2013-06-30 | $0 |
| 2013-03-31 | $0 |
| 2012-12-31 | $-0 |
| 2012-09-30 | $-0 |
| 2012-06-30 | $0 |
| 2012-03-31 | $0 |
| 2011-12-31 | $-0 |
| 2011-09-30 | $-0 |
| 2011-06-30 | $-0 |
| 2011-03-31 | $-0 |
| 2010-12-31 | $0 |
| 2010-09-30 | $-0 |
| 2010-06-30 | $-0 |
| 2010-03-31 | $-0 |
| 2009-12-31 | $-0 |
| 2009-09-30 | $-0 |
| 2009-06-30 | $-0 |
| 2009-03-31 | $-0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.028B | $0.017B |
| ImmuCell Corp. is a biotechnology company striving to build shareholder value by commercializing proprietary technologies and helping dairy and beef producers and their veterinarians manage disease and reproduction in their herds. The company is also conducting an open label, efficacy study of DiffGAM, a human application of its milk-derived passive antibodytechnology for use as an alternative to antibiotics in the treatment and/or prevention of Clostridium difficile-associated diarrhea. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $200.746B | 25.61 |
| Stryker (SYK) | United States | $148.041B | 33.36 |
| Boston Scientific (BSX) | United States | $130.832B | 37.61 |
| Medtronic (MDT) | Ireland | $112.819B | 16.79 |
| EssilorLuxottica (ESLOY) | France | $109.372B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.423B | 0.00 |
| Haleon (HLN) | United Kingdom | $41.781B | 27.15 |
| GE HealthCare Technologies (GEHC) | United States | $38.460B | 19.95 |
| ResMed (RMD) | United States | $34.562B | 28.40 |
| Terumo (TRUMY) | Japan | $29.203B | 41.24 |
| Koninklijke Philips (PHG) | Netherlands | $24.401B | 18.68 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.892B | 13.94 |
| Insulet (PODD) | United States | $18.873B | 75.16 |
| Baxter (BAX) | United States | $16.660B | 10.84 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.764B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.168B | 34.56 |
| BellRing Brands (BRBR) | United States | $9.324B | 39.42 |
| Demant (WILYY) | Denmark | $8.342B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.545B | 12.89 |
| TG Therapeutics (TGTX) | United States | $5.433B | 0.00 |
| Haemonetics (HAE) | United States | $4.610B | 22.50 |
| ICU Medical (ICUI) | United States | $4.280B | 40.75 |
| Prestige Consumer Healthcare (PBH) | United States | $4.067B | 20.23 |
| Perrigo (PRGO) | Ireland | $3.658B | 10.77 |
| Envista Holdings (NVST) | United States | $3.500B | 26.08 |
| Agios Pharmaceuticals (AGIO) | United States | $3.342B | 0.00 |
| Neogen (NEOG) | United States | $3.289B | 37.95 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.961B | 18.99 |
| QuidelOrtho (QDEL) | United States | $2.692B | 17.33 |
| LeMaitre Vascular (LMAT) | United States | $2.306B | 56.05 |
| Warby Parker (WRBY) | United States | $2.147B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.053B | 35.93 |
| AtriCure (ATRC) | United States | $1.765B | 0.00 |
| InMode (INMD) | Israel | $1.623B | 9.76 |
| Curaleaf Holdings (CURLF) | Canada | $1.456B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.425B | 10.19 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.420B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.118B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.024B | 18.05 |
| CeriBell (CBLL) | United States | $0.999B | 0.00 |
| Owens & Minor (OMI) | United States | $0.947B | 7.40 |
| National Vision Holdings (EYE) | United States | $0.872B | 29.13 |
| Evolus (EOLS) | United States | $0.776B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.768B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.703B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.685B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.569B | 17.18 |
| Surmodics (SRDX) | United States | $0.545B | 0.00 |
| Quanterix (QTRX) | United States | $0.476B | 0.00 |
| Valneva SE (VALN) | France | $0.403B | 0.00 |
| ZimVie (ZIMV) | United States | $0.383B | 32.23 |
| Canopy Growth (CGC) | Canada | $0.370B | 0.00 |
| Biote (BTMD) | United States | $0.364B | 8.00 |
| Viemed Healthcare (VMD) | United States | $0.356B | 33.89 |
| Cerus (CERS) | United States | $0.345B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.326B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.302B | 20.25 |
| Zynex (ZYXI) | United States | $0.259B | 54.20 |
| TerrAscend (TSNDF) | Canada | $0.255B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.249B | 0.00 |
| Omeros (OMER) | United States | $0.243B | 0.00 |
| MacroGenics (MGNX) | United States | $0.237B | 0.00 |
| Jin Medical (ZJYL) | China | $0.228B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.227B | 15.68 |
| High Tide (HITI) | Canada | $0.220B | 91.00 |
| Organigram Holdings (OGI) | Canada | $0.172B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.160B | 21.67 |
| Brainsway (BWAY) | Israel | $0.151B | 90.40 |
| TriSalus Life Sciences (TLSI) | United States | $0.137B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.134B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.119B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 11.23 |
| Ayr Wellness (AYRWF) | United States | $0.098B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 23.20 |
| Veru (VERU) | United States | $0.090B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.085B | 43.83 |
| Cellectar Biosciences (CLRB) | United States | $0.085B | 0.00 |
| Sanuwave Health (SNWVD) | United States | $0.081B | 2.74 |
| Jushi Holdings (JUSHF) | United States | $0.080B | 0.00 |
| Modular Medical (MODD) | United States | $0.073B | 0.00 |
| MariMed (MRMD) | United States | $0.065B | 0.00 |
| InterCure (INCR) | Israel | $0.060B | 0.00 |
| Safety Shot (SHOT) | United States | $0.057B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.051B | 0.00 |
| Apyx Medical (APYX) | United States | $0.050B | 0.00 |
| Exagen (XGN) | United States | $0.049B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.034B | 0.00 |
| Nephros (NEPH) | United States | $0.017B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.011B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Senestech (SNES) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 13.07 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |